SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-064485
Filing Date
2023-03-08
Accepted
2023-03-08 16:06:00
Documents
13
Period of Report
2023-03-02
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d478454d8k.htm   iXBRL 8-K 34161
2 EX-3.1 d478454dex31.htm EX-3.1 165648
  Complete submission text file 0001193125-23-064485.txt   363109

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vir-20230302.xsd EX-101.SCH 2835
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20230302_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20230302_pre.xml EX-101.PRE 11698
7 EXTRACTED XBRL INSTANCE DOCUMENT d478454d8k_htm.xml XML 3553
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 23716162
SIC: 2836 Biological Products, (No Diagnostic Substances)